Basic Materials / Specialty ChemicalsNSE
$389.45
+12.15 (+3.04%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-846.6M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$25.4B
P/E
0.5x
↓EV/EBITDA
7.6x
↓ROE
8.2%
↑Gross Margin
29.9%
↑Debt/Equity
0.35
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-20.9%
FCF CAGR
—
FCF margin
-102.7%
FCF / Net income
-2.83x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.29B · net income $2.65B · FCF $-7.49B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.29B | $7.29B | $6.94B | $9.16B | $14.73B |
| Net Income | $2.65B | $2.65B | $1.66B | $1.07B | $3.89B |
| EBITDA | $4.33B | $4.33B | $2.34B | $1.77B | $4.58B |
| EPS | 42.81 | 42.81 | 31.95 | 20.67 | 74.94 |
| Gross Margin | 29.9% | 29.9% | 19.8% | 24.6% | 30.8% |
| Operating Margin | -13.0% | -13.0% | -14.9% | -8.8% | 4.9% |
| Net Margin | 36.3% | 36.3% | 23.9% | 11.6% | 26.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.35 | 0.35 | 0.05 | 0.02 | 0.04 |
| Current Ratio | 8.72 | 8.72 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-7.49B | $-7.49B | $-846.6M | $664.4M | $547.0M |
| Returns | |||||
| ROE | 8.2% | 8.2% | 6.0% | 4.0% | 15.1% |
| Valuation | |||||
| P/E | 0.48 | 0.48 | 11.39 | 14.70 | 6.98 |
| EV/EBITDA | 7.56 | 7.56 | 8.60 | 9.05 | 6.09 |
| P/B | 0.67 | 0.67 | 0.68 | 0.59 | 1.05 |
| Growth & Yield | |||||
| Revenue Growth | 5.0% | 5.0% | -24.2% | -37.8% | — |
| EPS Growth | 34.0% | 34.0% | 54.6% | -72.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-6.9%
EPS terminal req.
$34.56
Spread vs growth
40.9%
5Y implied EPS CAGR
-0.5%
EPS terminal req.
$41.81
Spread vs growth
34.5%
10Y implied EPS CAGR
4.6%
EPS terminal req.
$67.34
Spread vs growth
29.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-39.2%
Start / end P/E
21.2x → 9.6x
EPS bridge
31.95 → 42.81
Residual
-18.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.